Nanogenic Solutions' Acquisition

Nanogenic Solutions was acquired by Ryboquin on July 19, 2018.

Nanogenics is developing LipTide, an artificial virus, which acts as a custom-built delivery system that can be modified to target different cell types and deliver different payloads. LipTide is a pro…

Articles about Nanogenic Solutions' Acquisition: